000 01478 a2200433 4500
005 20250513153811.0
264 0 _c19981211
008 199812s 0 0 eng d
022 _a0160-9289
024 7 _a10.1002/clc.4960211017
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFazio, S
245 0 0 _aDoxorubicin-induced cardiomyopathy treated with carvedilol.
_h[electronic resource]
260 _bClinical cardiology
_cOct 1998
300 _a777-9 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdrenergic alpha-Antagonists
_xadministration & dosage
650 0 4 _aAdrenergic beta-Antagonists
_xadministration & dosage
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aCarbazoles
_xadministration & dosage
650 0 4 _aCardiomyopathy, Dilated
_xchemically induced
650 0 4 _aCarvedilol
650 0 4 _aDoxorubicin
_xadverse effects
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHeart Failure
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aPropanolamines
_xadministration & dosage
650 0 4 _aRadiography, Thoracic
650 0 4 _aTime Factors
700 1 _aPalmieri, E A
700 1 _aFerravante, B
700 1 _aBonè, F
700 1 _aBiondi, B
700 1 _aSaccĂ , L
773 0 _tClinical cardiology
_gvol. 21
_gno. 10
_gp. 777-9
856 4 0 _uhttps://doi.org/10.1002/clc.4960211017
_zAvailable from publisher's website
999 _c9754209
_d9754209